Kawakami Y et al. |
Neutralization of leukotriene C4 and D4 activity by monoclonal and single-chain antibodies. |
2014 |
Biochim. Biophys. Acta |
pmid:24361619
|
An S et al. |
Molecular cloning of sheep lung dipeptidase: a glycosyl phosphatidylinositol-anchored ectoenzyme that converts leukotriene D4 to leukotriene E4. |
1994 |
Biochim. Biophys. Acta |
pmid:8054366
|
Gronert K et al. |
Endogenous sulfidopeptide leukotriene synthesis and 12-lipoxygenase activity in bullfrog (Rana catesbeiana) erythrocytes. |
1995 |
Biochim. Biophys. Acta |
pmid:7734448
|
Uno T et al. |
Participation of leukotriene D4 and tumor necrosis factor on lipopolysaccharide-induced airway hyperresponsiveness in guinea pigs. |
1997 |
Biol. Pharm. Bull. |
pmid:9145204
|
Tsuji T et al. |
Differential effects of beta2-adrenoceptor desensitization on the IgE-dependent release of chemical mediators from cultured human mast cells. |
2004 |
Biol. Pharm. Bull. |
pmid:15467193
|
Smyth TP et al. |
A substrate variant as a high-affinity, reversible inhibitor: insight from the X-ray structure of cilastatin bound to membrane dipeptidase. |
2003 |
Bioorg. Med. Chem. |
pmid:12614884
|
Maehr H and Yang R |
Structure optimization of a leukotriene D4 antagonist by combinatorial chemistry in solution. |
1997 |
Bioorg. Med. Chem. |
pmid:9113326
|
Tvaermose-Nielsen O et al. |
Discovery of OT4003, a novel, potent, and orally active cys-LT1 receptor antagonist. |
1997 |
Bioorg. Med. Chem. |
pmid:9061206
|
Hayashi S et al. |
Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: design, synthesis, and structure-activity relationships. |
2010 |
Bioorg. Med. Chem. |
pmid:20875743
|
Germain AR et al. |
Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells. |
2013 |
Bioorg. Med. Chem. Lett. |
pmid:23403082
|
von Sprecher A et al. |
Synthesis and SAR of a novel, potent and structurally simple LTD4 antagonist of the quinoline class. |
1998 |
Bioorg. Med. Chem. Lett. |
pmid:9871521
|
Chambers RJ et al. |
Development of new chromanol antagonists of leukotriene D4. |
1998 |
Bioorg. Med. Chem. Lett. |
pmid:9873435
|
Macdonald D et al. |
Substituted 2,2-bisaryl-bicycloheptanes as novel and potent inhibitors of 5-lipoxygenase activating protein. |
2008 |
Bioorg. Med. Chem. Lett. |
pmid:18276139
|
Bouchelouche K et al. |
The action of cysteinyl-leukotrienes on intracellular calcium mobilization in human detrusor myocytes. |
2001 |
BJU Int. |
pmid:11350414
|
Lärfars G et al. |
Activation of nitric oxide release and oxidative metabolism by leukotrienes B4, C4, and D4 in human polymorphonuclear leukocytes. |
1999 |
Blood |
pmid:9949184
|
Dannull J et al. |
Leukotriene C4 induces migration of human monocyte-derived dendritic cells without loss of immunostimulatory function. |
2012 |
Blood |
pmid:22323449
|
Jiang Y et al. |
CysLT2 receptors interact with CysLT1 receptors and down-modulate cysteinyl leukotriene dependent mitogenic responses of mast cells. |
2007 |
Blood |
pmid:17693579
|
Bautz F et al. |
Chemotaxis and transendothelial migration of CD34(+) hematopoietic progenitor cells induced by the inflammatory mediator leukotriene D4 are mediated by the 7-transmembrane receptor CysLT1. |
2001 |
Blood |
pmid:11369634
|
Ito Y et al. |
Guinea pig cysteinyl leukotriene receptor 2 (gpCysLT2) mediates cell proliferation and intracellular calcium mobilization by LTC4 and LTD4. |
2008 |
BMB Rep |
pmid:18315950
|
Bellamkonda K et al. |
The eicosanoids leukotriene D4 and prostaglandin E2 promote the tumorigenicity of colon cancer-initiating cells in a xenograft mouse model. |
2016 |
BMC Cancer |
pmid:27388564
|